bpc-157 news 2025 september Croatian scientist Predrag Sikiric has spent decades studying BPC-157, a peptide now popular on the gray market and within the MAHA movement. But, as US Health Secretary RFK Jr. pushes to expand The Peptide Reclassification Everyone's Talking

The cold temperature reduces the kinetic energy of molecules, thereby slowing down reactions that lead to peptide degradation

Michael Madaio, nephrologist, chair emeritus of the MCG Department of Medicine and the studys co-corresponding author

Our [BPC 157 Capsules]( are designed for stability in the GI tract, making them a focus for gut-related research, though the peptide is known to have systemic effects regardless of administration route

Patients should be counseled never to administer extra doses to make up for missed doses, as this could increase the risk of adverse effects without providing additional therapeutic benefit